Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / American Depositary Shares, each representing five ordinary shares, nominal value of (pound)0.003 per share
-
Shares outstanding
-
795M
-
Number of holders
-
76
-
Total 13F shares, excl. options
-
101M
-
Shares change
-
+16.5M
-
Total reported value, excl. options
-
$362M
-
Value change
-
+$59.9M
-
Put/Call ratio
-
1.72
-
Number of buys
-
33
-
Number of sells
-
-41
-
Price
-
$3.60
Significant Holders of Mereo BioPharma Group plc - American Depositary Shares, each representing five ordinary shares, nominal value of (pound)0.003 per share (MREO) as of Q2 2024
97 filings reported holding MREO - Mereo BioPharma Group plc - American Depositary Shares, each representing five ordinary shares, nominal value of (pound)0.003 per share as of Q2 2024.
Mereo BioPharma Group plc - American Depositary Shares, each representing five ordinary shares, nominal value of (pound)0.003 per share (MREO) has 76 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 101M shares
of 795M outstanding shares and own 12.64% of the company stock.
Largest 10 shareholders include Rubric Capital Management LP (15.3M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (11.8M shares), Rock Springs Capital Management LP (9.28M shares), MANGROVE PARTNERS IM, LLC (8.75M shares), JANUS HENDERSON GROUP PLC (7.88M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (6.71M shares), 683 Capital Management, LLC (5M shares), ALKEON CAPITAL MANAGEMENT LLC (4.7M shares), Frazier Life Sciences Management, L.P. (4.4M shares), and Clearline Capital LP (3.33M shares).
This table shows the top 76 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.